简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-01-14 16:37 Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors
2022-01-14 16:07 Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies
2022-01-13 19:04 SPIE, the International Society for Optics and Photonics, Announces Its 2022 Society Awards
2022-01-12 18:51 Perceval: CORCYM Announces the First Patient Implanted in China
2022-01-12 18:47 Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40th Annual J.P. Morgan Healthcare Conference
2022-01-11 18:17 QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of Directors
2022-01-11 09:58 Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology
2022-01-11 09:55 Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers
2022-01-11 09:45 Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma
2022-01-11 09:31 Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences
2022-01-10 14:29 Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines
2022-01-07 19:43 Leman Micro Devices: World-first Clinical Trial Proves Cuffless Mobile Device Sensor and App Measures Blood Pressure With Same Accuracy as Cuff-based Machines
2022-01-05 16:29 Galderma Successfully Completes Acquisition of ALASTIN Skincare®
2022-01-05 15:03 ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
2022-01-05 14:35 Alentis Therapeutics Starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis
2022-01-04 19:11 VEGANZONE Will Grow Vegan Community in 196 Countries!
2022-01-04 09:54 Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant
2021-12-30 14:42 LEO Pharma Announces FDA Approval of Adbry™ (tralokinumab) as the First and Only Treatment Specifically Targeting IL-13 for Adults With Moderate-to-Severe Atopic Dermatitis
2021-12-28 09:20 Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer
2021-12-23 18:13 ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer

Business Wire Weibo

Press Releases

Latest Releases